Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Share This

Latest Mizuho News

Mizuho Americas and Pursuit Launch AI Nonprofit Build Corps

Mizuho Americas and Pursuit Launch AI Nonprofit Build Corps

February 11, 2026
Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

February 4, 2026
Paypal’s network value is still huge following leadership shuffle, says Mizuho’s Dan Dolev

Paypal’s network value is still huge following leadership shuffle, says Mizuho’s Dan Dolev

February 3, 2026

Mizuho news from around the globe

back-to-top-blue